Back to search

Aristotle University Of Thessaloniki (AUTH)

Η επίδραση διαφόρων θεραπευτικών παρεμβάσεων στα επίπεδα γλυκόζης και ινσουλίνης, σε γυναίκες με σύνδρομο πολυκυστικών ωοθηκών

Abstract

dc:description

Insulin resistance is a common metabolic feature of polycystic ovarian syndrome (PCOS), linked to increased risk of long term morbidity from type 2 diabetes mellitus or cardiovascular disease, in affected patients. The aim of this prospective clinical study is to assess insulin resistance indices based on fasting glucose and insulin levels and compare the influence of various long term treatment schemes on insulin resistance, in PCOS patients. 157 PCOS patients and 30 healthy controls were included. Basal gonadotrophin, androgen, fasting glucose and fasting insulin levels were measured and the insulin resistance indices glucose to insulin ratio (GI ratio), HOMA2-%B, HOMA2-%S, HOMA2-IR and QUICKI were calculated. PCOS patients were randomly assigned to the following treatment schemes: 1) Ethinyl estradiol (EE) 30 μg+drospirenone (n=37), 2) EE 30 μg+desogestel (n=15), 3) EE 35 μg+cyproterone acetate (CA) 2 mg (n=20), 4) EE 35 μg + CA 52 mg (n=21), 5) Conjugated estrogens (CE) 1,25 mg+CA 50 mg (n=21), 6) 17β-estradiol (E2)+CA 50 mg (n=21), 7) Metformin (n=18). Nine PCOS patients with anovulatory infertility, who had laparoscopic ovarian drilling (LOD), were also included to the study. Hormonal and biochemical measurements were repeated at 3 and 6 months during treatment. Fasting insulin levels were independently correlated to body mass index (ΒΜΙ) (SB+0,387 p<0,001) and age (SB -0,213 p=0,004), GI ratio was correlated to waist circumference (W) (SB -0,348 p<0,001), age (SB +0,188 p<0,05), and free androgen index (FAI) (SB -0,163 p<0,05), HOMA2-%B to W (SB +0,286 p=0,001) and FAI (SB +0,253 p=0,002), HOMA2-%S and HOMA2-IR to ΒΜΙ (SB -0,372 p<0,001) and age (SB +0,223 p=0,003). Hormonal treatments resulted in significant reduction of FSH, LH, testosterone levels (p<0,001) and increase of SHBG (p<0,001), with consequent significant reduction of FAI values (p<0,001). There was no significant change in gonadotrophin and testosterone levels with metformin administration, although significant reduction of FAI levels was observed (p<0,05). There was significant increase in fasting insulin levels in the EE+drospirenone, CE+CA 50 mg, E2+cyproterone 50 mg patient groups (p<0,05), with marginal decrease of insulin levels in patients receiving metformin. Similarly, there was significant increase in HOMA2-%B values in patients receiving EE+drospirenone, CE+CA 50 mg or E2+CA 50 mg (p<0,05), with no change in metformin patients. There was significant reduction of insulin resistance, according to HOMA2-%S and HOMA2-IR indices, in patients receiving EE+drospirenone or E2+CA, and marginal improvement of the above indices in patients taking metformin. No significant changes of QUICKI index were noted in patients taking hormonal treatments. Finally, there was no significant change in fasting glucose and insulin levels, and in all insulin resistance indices in patients who had LOD. These results suggest that long term hormonal treatment with estrogens, progestogens or antiandrogens in PCOS patients could result in further decrease of insulin sensitivity, particularly in patients receiving oral contraceptive pills containing drospirenone, or combinations of natural occurring estrogens with large doses of cyproterone acetate. This change could increase long term metabolic and cardiovascular risk, at least in some patients. Useful criteria to select patients at risk could be obesity, abdominal fat distribution, young age, and severity of hyperandrogenaemia, according to FAI values.

Degree

thesis:*
Grantor dc:publisher
Aristotle University Of Thessaloniki (AUTH)
Year dc:date
2009

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Gkoutzioulis, Fotios
  • Γκουτζιούλης, Φώτιος

Subjects

dc:subject × 18

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/19507

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Gkoutzioulis, Fotios; Γκουτζιούλης, Φώτιος. Η επίδραση διαφόρων θεραπευτικών παρεμβάσεων στα επίπεδα γλυκόζης και ινσουλίνης, σε γυναίκες με σύνδρομο πολυκυστικών ωοθηκών. Aristotle University Of Thessaloniki (AUTH), 2009. http://hdl.handle.net/10442/hedi/19507